Intraocular lens power adjustment by a femtosecond laser: In vitro evaluation of power change, modulation transfer function, light transmission, and light scattering in a blue light-filtering lens.

PURPOSE: To evaluate intraocular lens (IOL) power, modulation transfer function (MTF), light transmission, and light scattering of a blue light-filtering IOL before and after power adjustment by a femtosecond laser obtained through increased hydrophilicity of targeted areas within the optic, creating the ability to build a refractive-index-shaping lens within an existing IOL. SETTING: John A. Moran Eye Center, University of Utah, Salt Lake City, Utah, USA. DESIGN: Experimental study. METHODS: Ten CT Lucia 601PY single-piece yellow hydrophobic acrylic IOLs were used in this study. The IOL power and MTF were measured with a power and modulation transfer function device. Light transmission was measured using a Lambda 35 UV-VIS spectrophotometer. Backlight scattering was assessed with a Scheimpflug camera within the IOL substance. All measurements were done with hydrated IOLs. The IOLs were also evaluated under light microscopy (LM) before and after laser adjustment. RESULTS: After laser adjustment, a mean power change of -2.037 diopters was associated with a MTF change of -0.064 and a light transmittance change of -1.4%. Backlight scattering increased within the IOL optic in the zone corresponding to the laser treatment at levels that are not expected to be clinically significant. Treated areas within the optic could be well appreciated under LM without damage to the IOLs. CONCLUSION: Power adjustment of a commercially available hydrophobic acrylic blue light-filtering IOL by a femtosecond laser produced an accurate change in dioptric power while not significantly affecting the quality of the IOL.

Biocompatibility of intraocular lens power adjustment using a femtosecond laser in a rabbit model.

PURPOSE: To evaluate the biocompatibility (uveal and capsular) of intraocular lens (IOL) power adjustment by a femtosecond laser obtained through increased hydrophilicity of targeted areas within the optic, creating the ability to build a refractive-index shaping lens within an existing IOL. SETTING: John A. Moran Eye Center, University of Utah, Salt Lake City, Utah, USA. DESIGN: Experimental study. METHODS: Six rabbits had phacoemulsification with bilateral implantation of a commercially available hydrophobic acrylic IOL. The postoperative power adjustment was performed 2 weeks after implantation in 1 eye of each rabbit. The animals were followed clinically for an additional 2 weeks and then killed humanely. Their globes were enucleated and bisected coronally just anterior to the equator for gross examination from the Miyake-Apple view to assess capsular bag opacification. After IOL explantation for power measurements, the globes were sectioned and processed for standard histopathology. RESULTS: Slitlamp examinations performed after the laser treatments showed the formation of small gas bubbles behind the lenses that disappeared within a few hours. No postoperative inflammation or toxicity was observed in the treated eyes, and postoperative outcomes and histopathological examination results were similar to those in untreated eyes. The power measurements showed that the change in power obtained was consistent and within ±0.1 diopter of the target. CONCLUSIONS: Consistent and precise power changes can be induced in the optic of commercially available IOLs in vivo by using a femtosecond laser to create a refractive-index shaping lens. The laser treatment of the IOLs was biocompatible.

Chemical basis for alteration of an intraocular lens using a femtosecond laser.

The chemical basis for the alteration of the refractive properties of an intraocular lens with a femtosecond laser was investigated. Three different microscope setups have been used for the study: Laser Induced Fluorescence (LIF) microscopy, Raman microscopy and coherent anti-Stokes Raman Scattering (CARS) microscopy. Photo-induced hydrolysis of polymeric material in aqueous media produces two hydrophilic functional groups: acid group and alcohol group. The spectral signatures identify two of the hydrophilic polar molecules as N-phenyl-4-(phenylazo)-benzenamine (C18H15N3) and phenazine-1-carboxylic acid (C13H8N2O2). The change in hydrophilicity results in a negative refractive index change in the laser-treated areas.

Creation of a refractive lens within an existing intraocular lens using a femtosecond laser.

PURPOSE: To assess the efficiency and effectiveness of the technology that creates a hydrophilicity-based refractive index change within a standard intraocular lens (IOL) to alter the refractive characteristics of the IOL. SETTING: Perfect Lens LLC, Irvine, California, USA. DESIGN: Experimental study. METHODS: The IOL used in this experiment was a standard hydrophobic model (EC-1Y). The refractive index of the material was changed by exposure of the material to a femtosecond laser and the subsequent absorption of water by the material. An experimental system using a femtosecond laser, an acoustic-optic modulator, beam-shaping optics, a scan system, and an objective lens was used to create the refractive index change within the IOL. Experiments were performed to determine the optimum wavelength, energy per pulse, and line spacing to produce the refractive index shaping lens. A power and modulation transfer function (MTF) measurement device for refractive and diffractive IOLs was used to measure the diopter and MTF before and after the creation of the refractive index shaping lens. RESULTS: The technology successfully altered the refractive characteristics of the IOL. The refractive index change altered the diopter (D) of the IOL (to within ±0.1 D of the targeted change) without significant diminution in the MTF (<0.1 or MTF ≥0.51 for the 100 lp/mm measurement). CONCLUSION: The refractive properties of an IOL can be altered by building a refractive index shaping lens within an IOL using a femtosecond laser with minimal diminution in MTF. FINANCIAL DISCLOSURE: All authors are employed by Perfect Lens, LLC and have a financial interest in the products of Perfect Lens, LLC.